Metastatic melanoma response to combination therapy with BRAF and MEK inhibitors: a FDG PET/CT pilot study

被引：0
|
作者：
Burroni, L.
Fringuelli, F.
Biscontini, G.
Palucci, A.
机构：
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0446
引用
收藏
页码：S586 / S587
页数：2
相关论文
共 50 条
  • [1] Documenting the histologic response of metastatic melanoma to combination therapy with BRAF and MEK inhibitors
    Mieczkowska, Karolina
    Jacob, Jack
    Paoluzzi, Luca
    Papalezova, Katia T.
    McLellan, Beth N.
    Amin, Bijal
    MELANOMA RESEARCH, 2022, 32 (02) : 128 - 129
  • [2] Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma
    Cann, Christopher G.
    Tillman, Benjamin F.
    Davis, Elizabeth J.
    Johnson, Douglas B.
    ONCOLOGIST, 2019, 24 (11): : 1495 - 1496
  • [3] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    K S M Smalley
    K T Flaherty
    British Journal of Cancer, 2009, 100 : 431 - 435
  • [4] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    Smalley, K. S. M.
    Flaherty, K. T.
    BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 431 - 435
  • [5] Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma
    Hui, Caressa
    Wu, Yufan
    Liu, Kevin
    Sandhu, Navjot
    Blomain, Erik
    Binkley, Michael
    Gephart, Melanie
    Chang, Steven
    Li, Gordon
    Reddy, Sunil
    Gibbs, Iris
    Soltys, Scott
    Pollom, Erqi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S48 - S49
  • [6] Cardiovascular monitoring in metastatic melanoma patients undergoing combination therapy with BRAF and MEK inhibitors
    Guglielmi, Giulia
    Sarocchi, Matteo
    Tini, Giacomo
    Schiavone, Arianna
    Toma, Matteo
    Spagnolo, Francesco
    Tanda, Enrica Teresa
    Boutros, Andrea
    Spallarossa, Paolo
    Porto, Italo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N20 - N21
  • [7] Impressive Rapid Complete Response on FDG PET/CT to BRAF Inhibitors in a Metastatic Melanoma With Massive Tumor Burden
    Abgral, Ronan
    Salaun, Pierre-Yves
    Sassolas, Bruno
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E180 - E181
  • [8] Study of the response of melanoma lines to BRAF/MEK inhibitors and combination drug treatments
    Dastur, Anahita
    Benes, Cyril
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors
    Annovazzi, Alessio
    Ferraresi, Virginia
    Rea, Sandra
    Russillo, Michelangelo
    Renna, Davide
    Carpano, Silvia
    Sciuto, Rosa
    EUROPEAN RADIOLOGY, 2022, 32 (05) : 3398 - 3407
  • [10] Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors
    Alessio Annovazzi
    Virginia Ferraresi
    Sandra Rea
    Michelangelo Russillo
    Davide Renna
    Silvia Carpano
    Rosa Sciuto
    European Radiology, 2022, 32 : 3398 - 3407
12345